These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 28109882)

  • 41. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.
    Douam F; Ploss A
    Trends Microbiol; 2018 Nov; 26(11):913-928. PubMed ID: 29933925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Yellow fever: a reemerging threat.
    Gardner CL; Ryman KD
    Clin Lab Med; 2010 Mar; 30(1):237-60. PubMed ID: 20513550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019.
    Nwachukwu William E; Oladejo J; Ofoegbunam CM; Anueyiagu C; Dogunro F; Etiki SO; Dachung BI; Obiekea C; Aderoju B; Akanbi K; Adeyemi IT; Famokun GA; Emelife O; Osamwonyi IW; Ochu CL; Abiode A; Ireye F; Chukwuji M; Ipadeola O; Saiki M; Okudo I; Nwodo D; Oteri JA; Ilori E; Mba N; Ihekweazu C
    BMC Public Health; 2022 Aug; 22(1):1644. PubMed ID: 36042438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages.
    Chen LH; Kozarsky PE; Visser LG
    Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importation of yellow fever into China: assessing travel patterns.
    Wilder-Smith A; Leong WY
    J Travel Med; 2017 Jul; 24(4):. PubMed ID: 28426111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A public health risk assessment for yellow fever vaccination: a model exemplified by an outbreak in the state of São Paulo, Brazil.
    Ribeiro AF; Tengan C; Sato HK; Spinola R; Mascheretti M; França AC; Port-Carvalho M; Pereira M; Souza RP; Amaku M; Burattini MN; Coutinho FA; Lopez LF; Massad E
    Mem Inst Oswaldo Cruz; 2015 Apr; 110(2):230-4. PubMed ID: 25946247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017.
    Dorigatti I; Hamlet A; Aguas R; Cattarino L; Cori A; Donnelly CA; Garske T; Imai N; Ferguson NM
    Euro Surveill; 2017 Jul; 22(28):. PubMed ID: 28749337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.
    Bifani AM; Ong EZ; de Alwis R
    Curr Treat Options Infect Dis; 2020; 12(4):398-409. PubMed ID: 33173445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Yellow fever control in Cameroon: where are we now and where are we going?
    Wiysonge CS; Nomo E; Mawo J; Ofal J; Mimbouga J; Ticha J; Ndumbe PM
    BMC Med; 2008 Feb; 6():3. PubMed ID: 18261201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever.
    Bifani AM; Ong EZ; de Alwis R
    Curr Treat Options Infect Dis; 2020; 12(3):349-360. PubMed ID: 32837338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Modern features of epidemiology and prophylaxis of yellow fever].
    Liashenko NI; Lukin EP
    Voen Med Zh; 2010 Jun; 331(6):32-6. PubMed ID: 20731094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania.
    Schönenberger S; Hatz C; Bühler S
    J Travel Med; 2016 May; 23(5):. PubMed ID: 27296582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study.
    Jean K; Raad H; Gaythorpe KAM; Hamlet A; Mueller JE; Hogan D; Mengistu T; Whitaker HJ; Garske T; Hocine MN
    PLoS Med; 2021 Feb; 18(2):e1003523. PubMed ID: 33600451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Yellow fever fact sheet.
    Wkly Epidemiol Rec; 2010 Jan; 85(5):33-6. PubMed ID: 20151492
    [No Abstract]   [Full Text] [Related]  

  • 56. Yellow fever in Africa and South America, 2015.
    Wkly Epidemiol Rec; 2016 Aug; 91(32):381-8. PubMed ID: 27522678
    [No Abstract]   [Full Text] [Related]  

  • 57. Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections.
    Monath TP; Craven RB; Adjukiewicz A; Germain M; Francy DB; Ferrara L; Samba EM; N'Jie H; Cham K; Fitzgerald SA; Crippen PH; Simpson DI; Bowen ET; Fabiyi A; Salaun JJ
    Am J Trop Med Hyg; 1980 Sep; 29(5):912-28. PubMed ID: 7435793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling.
    Jean K; Hamlet A; Benzler J; Cibrelus L; Gaythorpe KAM; Sall A; Ferguson NM; Garske T
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008304. PubMed ID: 32379756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on progress controlling yellow fever in Africa, 2004-2008.
    Wkly Epidemiol Rec; 2008 Dec; 83(50):450-8. PubMed ID: 19069294
    [No Abstract]   [Full Text] [Related]  

  • 60. Yellow fever: a disease that has yet to be conquered.
    Barrett AD; Higgs S
    Annu Rev Entomol; 2007; 52():209-29. PubMed ID: 16913829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.